Ryan Nelson
Editor-in-Chief, Medtech Insight, HBW Insight
Ryan has been covering the medical device and consumer health, wellness and beauty sectors since 2004, first as a reporter for Gray Sheet, where he covered beats including Capitol Hill, international and emerging technology, and then as managing editor of Rose Sheet. In his current role, he oversees and heads up strategy for their successor publications Medtech Insight and HBW Insight. He also manages and contributes regularly to HBW Insight’s Beauty channel with a focus on regulatory, policy and legal issues and has moderated related panels at industry events. Ryan has a growing role in developing podcasts, new features, “deep dive” article series, and infographics across teams and publications. Off the job, he enjoys spending time with his wife Katie, son Finn and daughter Maggie in Alexandria, VA, a DC suburb.
Latest From Ryan Nelson
P&G’s Mielle Acquisition, John Legend’s Loved01, And A Concealer For Hiding Hickeys; Beauty News In Brief
Textured hair-care specialist Mielle Organics will continue to be led by wife-and-husband duo Monique and Melvin Rodriguez within Procter & Gamble’s Beauty division, pending regulatory approval. More beauty M&A and product launch news.
Toying With Metaverse Marketing? BUXOM Cosmetics Opens Virtual Club In Decentraland
BUXOM Cosmetics has a go at marketing in the metaverse, launching PlumpVerse in Decentraland, a virtual reality platform powered by the Ethereum blockchain where users can purchase digital LAND to build and monetize content and applications.
Target Corporation Settles ‘Oil-Free’ Cosmetic Suit; Walmart And L’Oreal Next In Line
Putative class actions filed in recent years against leading beauty companies and retailers for alleged false and misleading “oil-free” claims on cosmetic products appear to be drawing to a close, more often than not via undisclosed settlements.
California DTSC Begins Taking Notifications Of Nail Products Containing Toluene
Effective 1 January, Nail Products Containing Toluene are the latest Priority Product adopted under California’s Safer Consumer Products regulation, requiring notifications from responsible entities by 2 March or 60 days after affected products enter the market. Alternatives analysis work will follow for companies that do not reformulate or discontinue products, among other options.
Compliance Clock Starts Ticking Under Historic Modernization of Cosmetic Regulations Act
Companies have one year to comply with US FDA registration and product listing requirements under the Modernization of Cosmetic Regulations Act of 2022, part of the $1.7tr omnibus spending package signed by President Joe Biden on 29 December. Trade groups applauded the historic milestone and the legislation’s departure from previous proposals, including the elimination of user fees.
Plaintiff Puts ‘Clean Beauty’ To Test In Federal Court In Sephora USA Case
The class action complaint in New York federal court suggests a parity between “clean” and natural claims in the understanding of beauty consumers.